{"id":"2b60a69b-12ef-47e0-9a1f-59e9b071331a","feedVisibility":"normal","congress":119,"billType":"hres","billNumber":396,"title":"Expressing support for the designation of the week of May 4, 2025, through May 10, 2025, as \"Tardive Dyskinesia Awareness Week\".","displayTitle":"表达对将2025年5月4日至5月10日这一周指定为“迟发性运动障碍宣传周”的支持。","abstract":"本决议支持指定“迟发性运动障碍宣传周”。迟发性运动障碍是一种以面部、躯干和四肢肌肉不自主、失控运动为特征的运动障碍。","displaySummary":"<p><strong>YVN Summary</strong></p>\n\n<p>迟发性运动障碍（TD）是一种不自主的运动障碍，会导致面部、躯干和四肢出现无法控制的重复性动作，可能作为长期使用某些精神科和胃肠道药物的副作用而发展。估计有6与名美国人受到影响，其中约 65%尚未得到诊断。该决议支持屨2025年5月4日至10日定为“迟发性运动障碍意识周”，并鼓励公众和医疗界进一步了解这一病症，因为FDA已批准了可以对患者产生实质帮助的治疗方法。</p>","status":"COMMITTEE_CONSIDERATION","topics":["HEALTHCARE"],"introducedAt":"2025-05-07T00:00:00+00:00","latestActionAt":"2025-05-07T00:00:00+00:00","congressGovUrl":"https://www.congress.gov/bill/119th-congress/house-resolution/396","accountabilityFlags":{},"tldr":"将2025年5月4日至10日定为迟发性运动障碍宣传周，指出虽已有FDA批准的治疗方法，但大多数病例仍未得到诊断。","summaryStandard":null,"flagExplainers":{},"flagValence":{},"needsResummary":false,"displaySummaryHtml":null,"rawStatusText":"Referred to the House Committee on Energy and Commerce.","chamber":"HOUSE","policyArea":"Health","legislativeSubjects":[],"lawStatus":null,"lawNumber":null,"latestActionText":"Referred to the House Committee on Energy and Commerce.","latestTextVersion":"Introduced in House","textVersionUsed":"Introduced in House","dateAdded":"2026-04-09T00:00:00+00:00","summarizedAt":"2026-04-09T00:00:00+00:00","recordId":"2b60a69b-12ef-47e0-9a1f-59e9b071331a","feedIdentityKey":"119/hres/396","websiteBillId":"HRES-396","yourvoiceSummary":"迟发性运动障碍（TD）是一种不自主的运动障碍，会导致面部、躯干和四肢出现无法控制的重复性动作，可能作为长期使用某些精神科和胃肠道药物的副作用而发展。估计有6与名美国人受到影响，其中约 65%尚未得到诊断。该决议支持屨2025年5月4日至10日定为“迟发性运动障碍意识周”，并鼓励公众和医疗界进一步了解这一病症，因为FDA已批准了可以对患者产生实质帮助的治疗方法。","updatedAt":"2026-10-24T12:02:48.814715+00:00"}